BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33329406)

  • 1. miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes.
    Scherm MG; Daniel C
    Front Endocrinol (Lausanne); 2020; 11():606322. PubMed ID: 33329406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T cell miRNAs for regulatory T cell induction in islet autoimmunity.
    Scherm MG; Serr I; Kaestner KH; Daniel C
    Mol Metab; 2019 Sep; 27S(Suppl):S122-S128. PubMed ID: 31500823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes.
    Scherm MG; Daniel C
    Curr Diab Rep; 2020 Jul; 20(9):41. PubMed ID: 32725277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes.
    Scherm MG; Serr I; Zahm AM; Schug J; Bellusci S; Manfredini R; Salb VK; Gerlach K; Weigmann B; Ziegler AG; Kaestner KH; Daniel C
    Nat Commun; 2019 Dec; 10(1):5697. PubMed ID: 31836704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity.
    Serr I; Fürst RW; Ott VB; Scherm MG; Nikolaev A; Gökmen F; Kälin S; Zillmer S; Bunk M; Weigmann B; Kunschke N; Loretz B; Lehr CM; Kirchner B; Haase B; Pfaffl M; Waisman A; Willis RA; Ziegler AG; Daniel C
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6659-E6668. PubMed ID: 27791035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
    Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
    Front Immunol; 2021; 12():635767. PubMed ID: 33815387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic Nanoparticles to Treat Islet Autoimmunity.
    Neef T; Miller SD
    Curr Diab Rep; 2017 Aug; 17(10):84. PubMed ID: 28791576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common patterns of gene regulation associated with Cesarean section and the development of islet autoimmunity - indications of immune cell activation.
    Laimighofer M; Lickert R; Fuerst R; Theis FJ; Winkler C; Bonifacio E; Ziegler AG; Krumsiek J
    Sci Rep; 2019 Apr; 9(1):6250. PubMed ID: 31000755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
    Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
    Front Immunol; 2019; 10():1637. PubMed ID: 31396209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
    Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
    Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation Followed by Antigen-Specific T
    Cabello-Kindelan C; Mackey S; Sands A; Rodriguez J; Vazquez C; Pugliese A; Bayer AL
    Diabetes; 2020 Feb; 69(2):215-227. PubMed ID: 31712320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory properties of pancreatic islet-derived stem cells co-cultured with T cells: Does it contribute to the pathogenesis of type 1 diabetes?
    Sariboyaci AE; Demircan PC; Gacar G; Unal ZS; Erman G; Karaoz E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):179-89. PubMed ID: 25014767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.
    Zheng Y; Wang Z; Zhou Z
    Cell Mol Immunol; 2017 Jun; 14(6):488-496. PubMed ID: 28317889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory roles of micro-RNAs in T cell autoimmunity.
    Esmailzadeh S; Mansoori B; Mohammadi A; Baradaran B
    Immunol Invest; 2017 Nov; 46(8):864-879. PubMed ID: 29058542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signature of regulatory T cells in health and autoimmunity.
    Soltanzadeh-Yamchi M; Shahbazi M; Aslani S; Mohammadnia-Afrouzi M
    Biomed Pharmacother; 2018 Apr; 100():316-323. PubMed ID: 29453041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Logic and extent of miRNA-mediated control of autoimmune gene expression.
    Vinuesa CG; Rigby RJ; Yu D
    Int Rev Immunol; 2009; 28(3-4):112-38. PubMed ID: 19811318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.